Skin repair & barrier protocols
Nucleotide actives are positioned for repair rather than volume.
Product Portfolio PN & PDRN Therapy
PN & PDRN
Clinical Formulations & Supply
Nucleotide-based regenerative solutions — PN and PDRN listed and specified as distinct categories.
In verification Published specifications
5 Application areas
On request Documentation basis
Polynucleotide (PN) and polydeoxyribonucleotide (PDRN) regenerative solutions for skin quality and repair protocols, supplied with OEM and private label support.
Application areas
Where pn / pdrn are specified
Match the treatment area to the product property that makes it suitable, then confirm the specification against your protocol.
Multi-vial regenerative courses
Vial-count configurations support repeat-session scheduling.
Combined nucleotide + exosome protocols
A combined PDRN and exosome option pairs two active categories.
Post-procedure recovery ranges
Repair-positioned products suit clinic recovery protocols.
Distributor range building
The category extends a regenerative portfolio beyond biostimulators.
Selection guide
How to choose
- 01
Clarify whether you need PN (polynucleotide) or PDRN (polydeoxyribonucleotide) — they are distinct categories and should be positioned separately.
- 02
Confirm the concentration and vial count per box, as regenerative protocols are typically multi-vial courses.
- 03
Decide between a standalone PN/PDRN product and a combined PDRN + exosome formulation.
- 04
Check the documentation set available for your market before committing to a launch.
Procurement
Key procurement factors
- PN vs PDRN category — do not conflate the two
- Concentration and vials per box
- Combined PDRN + exosome options
- Solutions vs lyophilized formats
- Course configuration
- Available product documentation
Documentation basis
This category is not covered by the published quality management certificates, which state a scope covering cross-linked hyaluronic acid dermal filler gel and medical sodium hyaluronate gel. Available documents vary by product and destination market.
Request documentation for this categoryBefore you order
Procurement checklist
Work through these points before placing a first order. Each one maps to a field on the technical specification sheet.
- Confirm whether your market needs PN, PDRN, or both as distinct lines
- Verify concentration and vials per box against your course design
- Decide between standalone and combined PDRN + exosome formats
- Check whether solution or lyophilized format suits your market
- Note that the published ISO certificates do not cover this category
- Confirm the market documentation set before committing to a launch
- Confirm the course configuration you will stock
- Confirm MOQ and lead time
Regulatory
Regulatory status — confirm before you commit
PN (polynucleotide) and PDRN (polydeoxyribonucleotide) are regulated differently across markets, and the position differs from market to market. Establish the classification for your destination market before ordering.
- In the United States, no PN or PDRN injectable product is approved as a dermal filler or skin booster.
- In South Korea, polynucleotide products have been approved by the Ministry of Food and Drug Safety (MFDS) under a medical device pathway.
- Approved dermal filler materials in the United States are limited to hyaluronic acid, collagen, calcium hydroxylapatite, poly-L-lactic acid and PMMA microspheres.
- Intended-use classification and import requirements vary by market and are handled separately from the quality management system certificate.
Buyer questions
PN / PDRN FAQ
Is PN the same as PDRN?
No. PN (polynucleotide) and PDRN (polydeoxyribonucleotide) are separate product categories with different molecular characteristics. They should be listed, specified and described as distinct products rather than as synonyms.
Are these products available with private label branding?
Yes, subject to the formulation and packaging configuration. Contact us with the product and market you are targeting to confirm availability and MOQ.
Can PDRN be combined with exosome?
A combined PDRN and exosome format is available. Confirm the exact composition and configuration on the specification sheet for the SKU you are considering.
Recommended reading
Guides for this category
Clinical Science
PN vs PDRN: Why They Are Not Interchangeable
In supplier catalogues, on price lists, and in quotation emails, PN and PDRN are routinely written as though they were the same material. They are not. They are two different categories of nucleic-acid-derived product, and a supplier who treats them as synonyms is telling you something about how carefully they document everything else.
Clinical Science
Exosome vs PDRN: What Aesthetic Buyers Should Know
Exosome and PDRN products are frequently presented side by side in supplier catalogs as though they were two versions of the same thing. They are not. They differ in what they are, how they are classified by regulators, and — most importantly for buyers — what documentation you can legitimately hold when you import them.
Private label
Own-brand pn / pdrn?
Logo, retail box, label, leaflet and blister paper can be customized on this range. MOQ and lead time depend on the formulation and packaging combination you choose.
Request for quotation
Request a quotation for PN / PDRN
Direct response with technical specifications, tiered quotation and country-specific documentation status.